The A.I. Diet

March 5, 2019

Press Release Department of Translational Medicine Translational Institute

LA JOLLA, CA – In a New York Times op-ed, Eric Topol, MD, founder and director of Scripps Research Translational Institute, discusses the science of nutrition and the need for diet to be individualized.

Click here if not automatically redirected.

News, Events & Media See all related news, events & media

In the Media

A look at ‘super agers’ and the science behind longer, sharper lives

PBS NewsHour

Translational Medicine Eric Topol, MD

In the Media

What a longevity expert eats in a day

The Washington Post

Translational Medicine Eric Topol, MD Translational Institute

In the Media

Myocarditis is a rare but real COVID vaccine side effect. A new study sheds light on what might cause it

STAT News

Translational Medicine Eric Topol, MD COVID-19

In the Media

Can AI look at your retina and diagnose Alzheimer’s? Eric Topol hopes so

WIRED

Translational Medicine Eric Topol, MD Alzheimer's Diseases Artificial Intelligence Translational Institute

In the Media

Best Leaders 2025: Eric Topol

US News & World Report

Translational Medicine Eric Topol, MD Awards & Honors Translational Institute

In the Media

Weight-loss drug Zepbound is being tested as a treatment for long COVID

WIRED

Translational Medicine Julia Moore Vogel, PhD Eric Topol, MD Long COVID Translational Institute

In the Media

Study finds COVID mRNA vaccines boost cancer treatment

Science Friday

Translational Medicine Eric Topol, MD COVID-19 Translational Institute Vaccines

News

Scripps Research scientists launch new digital clinical trial to test repurposed drug for long COVID symptom relief

Study will investigate whether a GIP/GLP-1 dual receptor agonist, currently approved for type 2 diabetes, obesity and obstructive sleep apnea, can reduce symptoms of long COVID.

Translational Medicine Translational Institute

Groundbreaking Science.

Life-changing Medicine.